Bruker Corp
BRKR
56.46
-5.64
-9.08%
Bruker Corp
US · BRKR
#1504 by market cap
Listed 1970
56.46
-5.64
-9.08%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
D-
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
2
■ Upgrades■ Downgrades
- 0 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: J.P. Morgan moved from Buy to Hold on 2026-10-13.
Analyst consensus 7 analysts
Buy
Avg price target 66.86 +18.4%
Price target rangecurrent 56.46
Low55.00
Avg66.86
High85.00
Buy 43%
Hold 43%
Sell 14%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-10 | Guggenheim | -- | Buy | 72.00 |
| 2026-11-05 | Citi | -- | Hold | 64.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 85.00 |
| 2026-11-05 | Barclays | -- | Buy | 70.00 |
| 2026-11-04 | Goldman Sachs | -- | Sell | 55.00 |
| 2026-11-04 | Guggenheim | -- | Buy | 72.00 |
| 2026-10-14 | J.P. Morgan | -- | Hold | 60.00 |
| 2026-10-13 | TD Cowen | -- | Hold | 62.00 |
| 2026-10-13 | J.P. Morgan | -- | Hold | 60.00 |
| 2026-10-07 | Barclays | -- | Buy | 70.00 |
| 2026-10-05 | Goldman Sachs | -- | Sell | 50.00 |
| 2026-10-01 | Guggenheim | -- | Buy | 72.00 |
| 2026-09-29 | Leerink Partners | -- | Buy | 80.00 |
| 2026-08-25 | Barclays | -- | Buy | 58.00 |
| 2026-08-06 | J.P. Morgan | -- | Buy | 60.00 |
| 2026-08-05 | Wells Fargo | -- | Buy | 55.00 |
| 2026-08-05 | BofA Securities | -- | Buy | -- |
| 2026-08-05 | Citi | -- | Hold | 53.00 |
| 2026-08-04 | Guggenheim | -- | Buy | 70.00 |
| 2026-07-08 | Citi | -- | Hold | 60.00 |
| 2026-06-29 | Guggenheim | -- | Buy | 70.00 |
| 2026-06-24 | Barclays | -- | Buy | 60.00 |
| 2026-06-08 | J.P. Morgan | -- | Buy | 65.00 |
| 2026-06-02 | BofA Securities | -- | Buy | 65.00 |
| 2026-06-01 | Wolfe Research | -- | Hold | -- |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-13 | J.P. Morgan | Buy → Hold | 60.00 |
| 2026-06-01 | Wolfe Research | Buy → Hold | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | -- | ±12.89% | +12.90% (beat) |
| 2026/Q2 | 2026-08-04 | -- | ±12.82% | -21.79% (beat) |
| 2026/Q1 | 2026-05-06 | -- | ±8.85% | +11.29% (beat) |
| 2025/Q4 | 2026-02-12 | -- | ±7.45% | -11.60% (beat) |
| 2025/Q3 | 2025-11-03 | -- | ±12.49% | -0.59% (in line) |
| 2025/Q2 | 2025-08-04 | -- | ±12.18% | -8.62% (in line) |
| 2025/Q1 | 2025-05-07 | -- | ±12.45% | +3.32% (in line) |
| 2024/Q4 | 2025-02-13 | -- | ±9.95% | -0.97% (in line) |
| 2024/Q3 | 2024-11-05 | -- | ±9.43% | +3.35% (in line) |
| 2024/Q2 | 2024-08-06 | -- | ±10.57% | -2.17% (in line) |
| 2023/Q4 | 2024-02-13 | -- | ±7.91% | +8.77% (beat) |
| 2023/Q3 | 2023-11-02 | -- | ±5.28% | -1.05% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.
Bruker Corp discussion 0 comments